Thinking of joining a study?

Register your interest

NCT05711108 | Recruiting | Diabetes


Continuous Glucose Monitoring (CGM) in Long Term Care (LTC) Facilities
Sponsor:

Joslin Diabetes Center

Brief Summary:

To prospectively determine the burden of hypoglycemia (minutes spent below 70 mg/dl per day, measured by continuous glucose monitor (CGM)) among residents of long term care facilities (LTC) with a diagnosis of type 1 or type 2 diabetes including key clinical subgroups (living in skilled nursing facility (SNF) or nursing home (NH), on different hypoglycemic medications). This aim will be achieved by recruiting 300 residents with diabetes in 4 LTC facilities. All participants will undergo masked CGM for 10 days.

Condition or disease

Diabetes

Hypoglycemia

Aging

Study Type : Observational
Estimated Enrollment : 300 participants
Official Title : Continuous Glucose Monitoring (CGM) to Assess Hypoglycemia in Older Adults With Diabetes in Long Term Care (LTC) Facilities
Actual Study Start Date : January 19, 2022
Estimated Primary Completion Date : April 2024
Estimated Study Completion Date : May 2024

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 65 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Criteria
Inclusion Criteria
  • Adults >64 years with diagnosis of type 1 or type 2 diabetes
  • Using glucose-lowering medication or insulin
Exclusion Criteria
  • Currently taking or planning to take hydroxyurea
  • Patient or Health care proxy refuses to sign consent form

Continuous Glucose Monitoring (CGM) in Long Term Care (LTC) Facilities

Location Details


Please Choose a site



Continuous Glucose Monitoring (CGM) in Long Term Care (LTC) Facilities

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


Recruiting

United States, Massachusetts

Joslin Diabetes Center

Boston, Massachusetts, United States, 02215

Loading...